Editorial · 31 Dec 2025
EditorialPublished Dec 2015
Metabolism and Metabonomics in Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is a genetic disease – changes to the cell’s DNA lead to malignant transformation and known hallmarks of cancer. Genetic or epigenetic mutations leading to altered expression levels and activation of oncogenes and oncosuppressor genes reprogram metabolism as well and this further promotes tumor progression. There are now many experimental and clinical proofs of the significance of cancer metabolic phenotype in cancer’s development, growth and metastasis.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Endocrinology & Diabetes Research.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalEndocrinology & Diabetes Research
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “M. Čuperlović-Culf”
